市場調査レポート

商品コード

1514919

性感染症診断市場：疾患タイプ別、診断テストタイプ別、デバイス別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Sexually Transmitted Disease Diagnostics Market, By Disease Type, By Diagnostic Test Type, By Device, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: 2024年05月11日
発行: AnalystView Market Insights
ページ情報: 英文 366 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 3,250 468,195円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷はできません。

PDF (5 User License)

USD 4,650 669,879円

レポートPDFを同一事業所内の5名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 5,650 813,939円

レポートPDF & Excelをを企業内すべての方がご利用頂けるライセンスです。PDF & Excel内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDF & Excelの印刷は可能です。印刷したもののご利用はPDF & Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

性感染症診断薬市場規模は2023年に923億4,534万米ドルとなり、2024年から2032年にかけてCAGR 5.5%で拡大

性感染症診断市場の市場力学

性病罹患率の上昇とPOC（ポイント・オブ・ケア）などの診断技術の進歩が市場需要を促進する見込み

性感染症診断薬市場は、世界の性感染症流行の増加によって大きく牽引されています。性感染症の伝播は、性行動の変化、ヘルスケアへのアクセスの悪さ、意識の低さなど、いくつかの要因によって促進されます。診断検査の必要性は、性感染症の定期的なスクリーニングを奨励する公衆衛生の取り組みや啓発キャンペーンによって推進されています。また、検査や治療につきまとう偏見が和らげば、人々は検査サービスを受ける可能性が高まります。政府機関や非営利団体は、調査の支援、スクリーニング・プログラムの実施、診断検査への資金援助などを通じて、STDの予防・管理対策を頻繁に支援しています。このような支援により、検査サービスがより利用しやすくなり、市場の拡大が促進されます。

迅速診断検査（RDT）、ポイントオブケア検査（POCT）、核酸増幅検査（NAAT）などの診断技術の発展により、STD診断の精度、スピード、アクセシビリティは向上しています。自動化と分子診断学の進歩は、検査手順の有効性をさらに高める。特にリソースが限られた環境や遠隔地では、分散型検査へのシフトにより、ポイント・オブ・ケア検査ソリューションの需要が高まっています。迅速な診断と迅速な治療は、携帯可能で使いやすい診断機器によって可能となり、STDの蔓延を食い止めるために不可欠です。

性感染症診断市場-主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.5%のCAGRで毎年成長すると推定されます。

疾患タイプ別では、HIV感染症の流行により、HIV/AIDS分野が2023年に最大市場シェアを示すと予測されています。

診断検査タイプ別では、ラボラトリー検査での新技術の採用が多いことから、ラボラトリー検査セグメントが2023年に主要な診断検査タイプでした。

デバイス別では、ラボ検査デバイスの需要が高いため、2023年にはラボ検査デバイスセグメントがデバイスのトップでした。

地域別では、北米が先進ヘルスケアソリューションの存在により、2023年の主要収益源でした。

性感染症診断市場-セグメンテーション分析：

世界の性感染症診断市場は、疾患タイプ、診断テストタイプ、デバイス、地域に基づいてセグメント化されます。

市場は疾患タイプに基づいて6つに分類される：クラミジア、淋病、梅毒、性器ヘルペス、B型肝炎、HIV/AIDSです。HIV/AIDS分野が市場を独占しています。梅毒、淋病の有病率の増加も市場の成長を後押ししています。

同市場は、診断検査タイプによってラボ検査とPOC検査の2つに分類されます。ラボ検査分野が市場を独占しています。ポイントオブケア検査は、予測期間中に最も速いCAGRで成長すると予測されます。

同市場は、デバイス別にラボ用デバイスとPOC用デバイスの2つに分類されます。ラボラトリー機器分野は市場を独占しており、予測期間中も高い優位性を維持すると予測されます。血液検査やその他の身体検査機器に対する高い需要が、同分野の成長を後押ししています。

性感染症診断市場-地理的洞察

世界的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。北米は性感染症診断薬の圧倒的な市場です。アジア太平洋地域では、特に中国やインドなどの新興経済圏における医療支出の増加が、性病診断市場の拡大に寄与しています。検査室や検査施設を含むヘルスケアインフラへの投資拡大により、診断サービスへのアクセスが向上しています。

性感染症診断市場-競合情勢：

性感染症診断市場は適度に統合されています。市場参入企業は、技術革新、市場開拓、パートナーシップなどの戦略的活動に取り組み、製品・サービスのポートフォリオを拡大し、世界各地に進出しています。診断会社、ヘルスケアプロバイダー、公衆衛生機関の連携により、革新的な診断ソリューションの開発と展開が促進されます。また、パートナーシップは市場リーチの拡大や流通経路の改善にも役立ちます。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋地域
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東およびアフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第11章主要ベンダー分析- 性感染症診断業界

競争ダッシュボード
企業プロファイル
- Abbott Laboratories
- Becton, Dickinson and Company（BD）
- Roche Diagnostics
- Cepheid
- Hologic, Inc.
- bioMerieux
- Siemens Healthineers
- QIAGEN Inc.
- Danaher Corporation
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- GenMark Diagnostics
- OraSure Technologies
- Mylan NV
- Alere Inc.
- Others

第12章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Sexually Transmitted Disease Diagnostics Market: Disease Type Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Disease Type
TABLE Global Sexually Transmitted Disease Diagnostics Market, by Disease Type 2019-2032 (USD Million)
TABLE Sexually Transmitted Disease Diagnostics Market: Diagnostic Test Type Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Diagnostic Test Type
TABLE Global Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type 2019-2032 (USD Million)
TABLE Sexually Transmitted Disease Diagnostics Market: Device Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Device
TABLE Global Sexually Transmitted Disease Diagnostics Market, by Device 2019-2032 (USD Million)
TABLE Sexually Transmitted Disease Diagnostics Market: Regional snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Sexually Transmitted Disease Diagnostics Market, by Region 2019-2032 (USD Million)
TABLE North America Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
TABLE North America Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
TABLE North America Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
TABLE North America Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)

List of Figures

FIGURE Sexually Transmitted Disease Diagnostics Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2024
FIGURE Disease Type segment market share analysis, 2024 & 2032
FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Diagnostic Test Type segment market share analysis, 2024 & 2032
FIGURE Diagnostic Test Type segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Device segment market share analysis, 2024 & 2032
FIGURE Device segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2024 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE North America Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
FIGURE Europe Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
FIGURE Asia Pacific Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
FIGURE Latin America Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
FIGURE North America market share analysis by country, 2024
FIGURE U.S. Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Canada Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Europe Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
FIGURE Germany Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Spain Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Italy Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE France Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE UK Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Russia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Netherlands Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Sweden Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Poland Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Rest of the Europe Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Asia Pacific Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
FIGURE India Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE China Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Japan Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE South Korea Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Australia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Thailand Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Indonesia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Philippines Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Rest of APAC Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Latin America Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Latin America Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
FIGURE Brazil Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Mexico Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Argentina Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Colombia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Rest of LATAM Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
FIGURE Saudi Arabia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE United Arab Emirates Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Israel Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Turkey Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Algeria Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Egypt Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
FIGURE Rest of MEA Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)

Product Code: ANV3033

REPORT HIGHLIGHT

Sexually Transmitted Disease Diagnostics Market size was valued at USD 92,345.34 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Diagnostics for sexually transmitted diseases (STDs) are the several techniques and examinations used to find out if a person has a sexually transmitted infection (STI). These tests are essential for the early diagnosis, management, and control of sexually transmitted infections.

Sexually Transmitted Disease Diagnostics Market- Market Dynamics

Rising prevalence of STDs and advancement in diagnostics technologies like Point of Care (POCs) are expected to propel market demand

The market for STD diagnostics is significantly driven by the increased prevalence of STDs across the globe. The transmission of sexually transmitted diseases is facilitated by several factors, including altered sexual behavior, poor access to healthcare, and low awareness. The need for diagnostic testing is driven by public health efforts and awareness campaigns that encourage routine screening for sexually transmitted diseases. People are also more likely to seek testing services when efforts are made to lessen the stigma attached to testing and treatment. Through supporting research, putting screening programs into place, and providing financial assistance for diagnostic testing, government entities and non-profit groups frequently support STD prevention and control measures. This support makes testing services more accessible, which propels market expansion.

The accuracy, speed, and accessibility of STD diagnostics have been enhanced by developments in diagnostic technologies, such as rapid diagnostic tests (RDTs), point-of-care testing (POCTs), and nucleic acid amplification tests (NAATs). Automation and advances in molecular diagnostics increase the effectiveness of testing procedures even more. Point-of-care testing solutions are in high demand due to the shift towards decentralized testing, especially in settings with limited resources or remote locations. Rapid diagnosis and prompt treatment are made possible by portable, user-friendly diagnostic equipment, which is essential for halting the spread of STDs.

Sexually Transmitted Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on Disease Type segmentation, the HIV/AIDS segment was predicted to show maximum market share in the year 2023, owing to the prevalence of HIV infections.

Based on Diagnostic Test Type segmentation, the laboratory testing segment was the leading Diagnostic Test Type in 2023, due to the high adoption of new tech at laboratory testing.

Based on Device segmentation, the laboratory devices segment was the leading Device in 2023, owing to the high demand for laboratory testing devices.

Based on region, North America was the leading revenue generator in 2023, owing to the presence of advanced healthcare solutions.

Sexually Transmitted Disease Diagnostics Market- Segmentation Analysis:

The Global Sexually Transmitted Disease Diagnostics Market is segmented based on Disease Type, Diagnostic Test Type, Device, and Region.

The market is divided into six categories based on Disease Type: Chlamydia, Gonorrhea, Syphilis, Genital herpes, Hepatitis B, and HIV/AIDS. The HIV/AIDS segment dominates the market. The growing prevalence of syphilis, gonorrhea, is also boosting the market growth.

The market is divided into two categories based on the Diagnostic Test Type: laboratory test and point of care testing. The laboratory testing segment dominates the market. The point of care testing is estimated to grow at the fastest CAGR over the forecast period.

The market is divided into two categories based on Device: laboratory devices and POC devices. The laboratory devices segment dominates the market and is expected to maintain its high dominance during the forecast period. High demand for blood tests, and other body testing devices are augmenting the segment growth.

Sexually Transmitted Disease Diagnostics Market- Geographical Insights

Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is a dominating market for Sexually Transmitted Disease Diagnostics. In Asia Pacific, the increasing healthcare spending, particularly in emerging economies like China, India, contributes to the expansion of the STD diagnostics market. Greater investment in healthcare infrastructure, including laboratories and testing facilities, improves access to diagnostic services.

Sexually Transmitted Disease Diagnostics Market- Competitive Landscape:

The sexually transmitted disease diagnostics market is moderately consolidated. Market players are involved in strategic activities like technology innovation, development, and partnerships to expand their product & service portfolio and reach across the globe. Collaboration between diagnostic companies, healthcare providers, and public health agencies facilitates the development and deployment of innovative diagnostic solutions. Partnerships can also help expand market reach and improve distribution channels.

Recent Developments:

In May 2022, Qiagen Inc. introduced NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission.

In May 2022, The Food and Drug Administration approved Abbott's Alinity m STI Assay for STIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET KEY PLAYERS

Abbott Laboratories
Becton, Dickinson and Company (BD)
Roche Diagnostics
Cepheid
Hologic, Inc.
bioMerieux
Siemens Healthineers
QIAGEN Inc.
Danaher Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
GenMark Diagnostics
OraSure Technologies
Mylan N.V.
Alere Inc.
Others

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

Chlamydia
Gonorrhea
Syphilis
Genital herpes
Hepatitis B
HIV/AIDS

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST TYPE- MARKET ANALYSIS, 2019-2032

Laboratory Testing
Point Of Care Testing

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DEVICE- MARKET ANALYSIS, 2019-2032

Laboratory Devices
Point of Care Devices

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Sexually Transmitted Disease Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Sexually Transmitted Disease Diagnostics Market Snippet by Disease Type
- 2.1.2. Sexually Transmitted Disease Diagnostics Market Snippet by Diagnostic Test Type
- 2.1.3. Sexually Transmitted Disease Diagnostics Market Snippet by Device
- 2.1.4. Sexually Transmitted Disease Diagnostics Market Snippet by Country
- 2.1.5. Sexually Transmitted Disease Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Sexually Transmitted Disease Diagnostics Key Market Trends

3.1. Sexually Transmitted Disease Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Sexually Transmitted Disease Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Sexually Transmitted Disease Diagnostics Market Opportunities
3.4. Sexually Transmitted Disease Diagnostics Market Future Trends

4. Sexually Transmitted Disease Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Sexually Transmitted Disease Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Sexually Transmitted Disease Diagnostics Market Landscape

6.1. Sexually Transmitted Disease Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Sexually Transmitted Disease Diagnostics Market - By Disease Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 7.1.2. Chlamydia
- 7.1.3. Gonorrhea
- 7.1.4. Syphilis
- 7.1.5. Genital herpes
- 7.1.6. Hepatitis B
- 7.1.7. HIV/AIDS

8. Sexually Transmitted Disease Diagnostics Market - By Diagnostic Test Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnostic Test Type, 2024 & 2032 (%)
- 8.1.2. Laboratory Testing
- 8.1.3. Point Of Care Testing

9. Sexually Transmitted Disease Diagnostics Market - By Device

9.1. Overview
- 9.1.1. Segment Share Analysis, By Device, 2024 & 2032 (%)
- 9.1.2. Laboratory Devices
- 9.1.3. Point of Care Devices

10. Sexually Transmitted Disease Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sexually Transmitted Disease Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Becton, Dickinson and Company (BD)
- 11.2.3. Roche Diagnostics
- 11.2.4. Cepheid
- 11.2.5. Hologic, Inc.
- 11.2.6. bioMerieux
- 11.2.7. Siemens Healthineers
- 11.2.8. QIAGEN Inc.
- 11.2.9. Danaher Corporation
- 11.2.10. Thermo Fisher Scientific
- 11.2.11. Bio-Rad Laboratories
- 11.2.12. GenMark Diagnostics
- 11.2.13. OraSure Technologies
- 11.2.14. Mylan N.V.
- 11.2.15. Alere Inc.
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

性感染症診断市場：疾患タイプ別、診断テストタイプ別、デバイス別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Sexually Transmitted Disease Diagnostics Market, By Disease Type, By Diagnostic Test Type, By Device, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

レポートハイライト

性感染症診断市場-セグメンテーション分析：

性感染症診断市場-競合情勢：

目次

第1章 性感染症診断市場概要

第2章 エグゼクティブサマリー

第3章 性感染症診断の主要市場動向

第4章 性感染症診断産業の調査

第5章 性感染症診断市場： COVID-19の影響分析

第6章 性感染症診断市場情勢

第7章 性感染症診断市場- 疾患タイプ別

第8章 性感染症診断市場- 診断テストタイプ別

第9章 性感染症診断市場- デバイス別

第10章 性感染症診断市場-地域別

第11章 主要ベンダー分析- 性感染症診断業界

第12章 アナリストの全方位展望